Also trades as: 601607.SS (SHH) · $vol 28M · 2607.HK (HKSE) · $vol 3M · SHPMF (OTC) · $vol 0M

$7.08

+0.67 (+10.42%)

OTC · Healthcare · Medical - Distribution · Tech Score Neutral · Power 53 · $5.2B mcap · 212M float · 0.0001% daily turnover · Short 57% of daily vol

Revenue

$275.3B +5.7% ▲

5Y CAGR: +8.1%

Gross Profit

$30.6B -2.2% ▼

5Y CAGR: +2.7%

Operating Income

$8.1B +6.2% ▲

5Y CAGR: -1.8%

Net Income

$4.6B +20.8% ▲

5Y CAGR: +2.2%

EPS (Diluted)

$6.15 +20.6% ▲

5Y CAGR: -3.1%

EBITDA

$12.1B +10.6% ▲

5Y CAGR: +5.2%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$191.9B	$215.8B	$232.0B	$260.3B	$275.3B
YoY Growth	+2.9%	+12.5%	+7.5%	+12.2%	+5.7%
Cost of Revenue	$164.5B	$187.3B	$201.5B	$229.0B	$244.6B
Gross Profit	$27.4B	$28.5B	$30.5B	$31.3B	$30.6B
Gross Margin	14.3%	13.2%	13.1%	12.0%	11.1%
R&D Expenses	$1.7B	$2.0B	$2.1B	$2.2B	$2.4B
SG&A Expenses	$14.2B	$14.7B	$15.5B	$10.9B	$9.5B
Operating Expenses	$19.3B	$20.6B	$21.7B	$23.7B	$22.5B
Operating Income	$7.2B	$8.2B	$9.0B	$7.7B	$8.1B
Operating Margin	3.7%	3.8%	3.9%	2.9%	3.0%
Interest Expense	$1.4B	$1.5B	$1.7B	$1.7B	$1.6B
Income Before Tax	$7.2B	$8.1B	$8.8B	$7.1B	$8.0B
Tax Expense	$1.6B	$1.9B	$1.8B	$1.9B	$2.1B
Net Income	$4.5B	$5.1B	$5.6B	$3.8B	$4.6B
Net Margin	2.3%	2.4%	2.4%	1.4%	1.7%
EPS (Diluted)	$7.90	$8.95	$8.05	$5.10	$6.15
EBITDA	$9.9B	$11.3B	$12.4B	$10.9B	$12.1B
Shares Outstanding	568M	568M	697M	740M	740M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$70.2B	$65.6B	$70.8B	$70.8B	$73.1B	$68.5B	$75.3B	$72.0B
Cost of Revenue	$63.2B	$58.2B	$63.5B	$63.2B	$65.6B	$60.5B	$67.2B	$64.3B
Gross Profit	$7.0B	$7.5B	$7.3B	$7.7B	$7.4B	$8.0B	$8.1B	$7.7B
Gross Margin	10.0%	11.4%	10.3%	10.8%	10.2%	11.7%	10.8%	10.7%
R&D Expenses	$511M	$778M	$497M	$462M	$554M	$825M	$468M	$451M
SG&A Expenses	$8.6B	-$4.1B	$4.1B	$360M	$4.8B	$5.0B	$4.6B	-$69M
Operating Expenses	$5.2B	$6.0B	$5.1B	$3.0B	$6.0B	$6.4B	$5.7B	$4.9B
Operating Income	$1.8B	$1.5B	$2.1B	$4.7B	$1.5B	$1.6B	$2.4B	$3.2B
Operating Margin	2.6%	2.2%	3.0%	6.6%	2.0%	2.3%	3.2%	4.5%
Interest Expense	$586M	$239M	$444M	$338M	$391M	$405M	$348M	$357M
Income Before Tax	$1.8B	$1.4B	$2.2B	$4.7B	$1.5B	$1.5B	$2.4B	$3.2B
Tax Expense	$396M	$529M	$513M	$1.3B	$483M	$534M	$569M	$719M
Net Income	$1.1B	$498M	$1.3B	$3.1B	$685M	$581M	$1.4B	$2.1B
Net Margin	1.6%	0.8%	1.9%	4.4%	0.9%	0.8%	1.9%	2.9%
EPS (Diluted)	$1.50	$0.65	$1.80	$4.20	$0.95	$0.75	$1.90	$2.80
EBITDA	$2.6B	$1.6B	$3.0B	$2.7B	$1.8B	$2.5B	$2.8B	$3.3B
Shares Outstanding	741M	741M	741M	741M	742M	743M	746M	742M

SHPMY OTC